The identification of etiological agents in feral fish neoplasia epizootics has been hampered in part by the lack of suitable fish models, and complicated by the likely existence of environmental agents which can act to stimulate or reduce population responses to genotoxin insult. The response of fish to tumor inhibitors and promoters, and the underlying mechanisms of modulation, have been studied in the rainbow trout model. Dietary treatment of trout with the compounds indole-3-carbinol (13C), ,8-naphthofiavone (BNF), or the polychlorinated biphenyl (PCB) complex Aroclor 1254, before and during exposure to afiatoxin B1 (AFB1), was shown to reduce the final incidence of hepatocellular carcinoma after 12 months, compared to fish receiving AFB1 only. By contrast, treatment of trout with BNF or I3C following AFB1 initiation led to a significant enhancement of ultimate tumor response. Similarly, simultaneous treatment of trout with PCB and the carcinogen N-nitrosodiethylamine led to syncarcinogenic enhancement, rather than inhibition, of tumor response.
Introduction
Aquatic pollutants including polycyclic aromatic hydrocarbons and nitrogen heterocycles have been associated with elevated incidences of neoplasia in feral fish populations (1) (2) (3) . However, direct demonstration of causal relationships remain to be established. While a number of studies have demonstrated the responsiveness of laboratory fish to carcinogens, most studies have concentrated on carcinogens such as aflatoxin B1 (AFB1) and N-nitrosodiethylamine (DEN), which have more relevance to neoplasia in man than in feral fish (4, 5) . An exception is the environmental pollutant benzo(a)pyrene (BP), which was recently shown to be carcinogenic to rainbow trout (6) .
Identification of etiological agents in feral fish neoplasia is further complicated by the almost certain presence of compounds which may act as modulators (promoters, inhibitors, cocarcinogens) of environmental carcinogen response. Recent studies have begun to examine the possible effects on tumor response and mechanisms of action of carcinogenesis modulators in fish. We review here the studies of carcinogenesis and its modulation in a convenient laboratory fish model, the rainbow trout. Most of these studies have examined modulation of AFB1 hepatocarcinogenesis by polychlorinated biphenyls (PCBs) and other agents. AFB1, a highly potent mycotoxin, was initially identified as a human carcinogen following its discovery as the etiological agent in outbreaks of hepatocellular carcinoma in trout hatcheries (7) . Though it is a dietary rather than an aquatic pollutant, studies on AFB1 carcinogenesis modulation in trout by PCB and other agents do serve to indicate the extent to which carcinogenesis by genotoxic pollutants may be modulated in fish, and the possible mechanisms through which modulation can occur. Clearly, there is a need for similar studies using BP and other carcinogens directly relevant to the aquatic environment.
Tumor Studies in Trout and Other Laboratory Fish Models
The response of rainbow trout and other laboratory fish models to known mammalian carcinogens has been recently reviewed (4, 5, 8, 9) , and will only be summa-rized here. Carcinogen classes tested have included: mycotoxins; polycyclic aromatic hydrocarbons (PAHs); nitrosamines, nitrosamides, and other alkylating agents; heterocyclic amines; steroids and cyclic lipids; chlorinated hydrocarbon pesticides; and azo compounds. Several species of small aquarium fish have been tested for carcinogen response. Early studies of the zebra danio (Brachydanio rer?io) and the guppy (Lebistes reticulatus) (10) (11) (12) (13) (14) (15) (16) (17) , and later experiments with the Japanese medaka (Oryzias latipes), the species Poeciliopsis, and other aquarium fish (18) (19) (20) (21) (22) (23) , have revealed liver to be a major target organ and hepatocellular carcinoma to be the most prevalent tumor type in fish carcinogenic response. Hepatocellular carcinoma is also the most common neoplastic response in trout (9, (24) (25) (26) (27) (28) , though other neoplasms, including nephroblastoma, gastric and swim bladder papillary adenoma, and fibrosarcoma can be induced, depending on carcinogen used, exposure route, and dose. For example, dietary exposure to Nmethyl-N'-nitro-N-nitrosoguanidine (MNNG) induces only gastric papillary adenomas in rainbow trout, whereas embryonic or fry water exposure to a solution of MNNG also induces hepatocellular carcinoma, nephroblastoma, and swim bladder papillary adenoma (8) . The malignancy of some of these neoplasms has been demonstrated by transplantation into isogenic hosts (29, and Hendricks and Bailey, unpublished results). A summary of all reported tissue lesions in aquatic animals resulting from controlled xenobiotic exposures has recently been compiled (30) , and the histological progression of liver neoplasms in rainbow trout has been reviewed (31, 32) .
Modulation of Carcinogenesis in Rainbow Trout
The response of rainbow trout to modulators of carcinogenesis depends on the initiator (carcinogen) used, the nature and dose of the modulator, and the relative timing of initiator and modulator exposure. As shown in Table 1 (38) . However, PCBs do not provide universal protection against all carcinogens in trout. As shown in experiment 3, coexposure to Aroclors 1254 or 1242 actually enhances DEN hepatocarcinogenesis in trout. In this context it is interesting that the incidence of neoplasias in English sole in the Puget Sound shows a negative correlation with PCB levels in the sediment (39) , suggesting that the initiator(s) of these tumors may be susceptible to PCB anticarcinogenesis rather than enhancement. It is important to note that PCBs have not proven to be carcinogenic to trout, or to any other fish species to our knowledge (e.g., experiment 2 PCB control), nor have we yet demonstrated promotion of carcinogenesis in trout by these compounds.
Mechanisms of Tumor Modulation in Trout
The tumor results outlined in Table 1 (44) , are potent inducers of cytochrome P448 and associated hepatic mixed function oxidase activities in trout. The following studies examined the extent to which these responses could be correlated with altered AFB1 phannacokinetics in vivo, cellular activation and detoxication reactions, and formation and/or persistence of liver DNA adducts, as possible mechanisms for inhibition during the initiation phase of carcinogenesis.
The effects of dietary modulators on cellular carcinogen metabolism and mutagenesis can be readily assessed using freshly isolated trout hepatocytes in shorttern culture (40,45-4 7) . Hepatocytes have been isolated from trout prefed control diet or diet containing appropriate levels of BNF, PCB, or I3C, and incubated under standard conditions with [3H]AFB1. The results of these studies are summarized in Table 2 . The known enzyme-inducing behavior of dietary BNF and PCB is accompanied by major changes in AFB1 metabolism. Both compounds cause a massive increase in the production of the relatively less carcinogenic metabolite aflatoxin Ml (AFM1), a substantial decrease in the production ofthe highly carcinogenic aflatoxicol (AFL), and a decrease of 40 perturbation in production of AFB1 metabolites, but did cause a significant decrease in DNA adduct formation. Thus the three anticarcinogens appear capable of reducing initial AFB1-DNA damage at the cellular level, but not by the same mechanisms.
At the whole organism level, alterations in cellular carcinogen metabolism, along with modified transport processes or other effects, may operate to alter carcinogen distribution and elimination kinetics. The effects of PCB, I3C, and BNF on AFB1 pharmacokinetics in trout have been extensively studied (48,49, unpublished results). Figure 1 summarizes some of the results of these studies. The major effect of all three inhibitors is a significant increase in vivo in the rate of elimination of AFB1 polar metabolites in bile, with I3C showing the smallest effect. (Effects of these dietary compounds on another potentially important pharnacokinetic pool, urine, were not included and are currently under study in our laboratory.) As in the hepatocyte studies, effects of these compounds were not identical, but were studied at only one dose each, that showing inhibition in the tumor studies. Though pharmacokinetic studies are highly laborious, it would be interesting to know if differences reported here are consistently maintained over a range of dietary concentrations of the three anticarcinogens.
The structures of the AFB1 metabolites found in rainbow trout bile have been previously established in our laboratory, and found to consist almost entirely of glucuronides of AFL and AFL-M1 (50) . Bile collected from the same fish depicted in Figure 1 was analyzed on HPLC as published (50) . As summarized in Figure 2 , alterations in the levels of bile radioactivity in fish fed control, BNF, PCB, and I3C diets were accounted for by increases in AFL-M1 glucuronide, with 13C again showing the smallest effect. (48) and (49) and are reproduced with permission.
We were concerned that our data did not indicate directly the extent of involvement of glutathione (GSH) conjugation as a detoxication pathway for AFB1 in trout. This reaction may be especially significant since it traps the activated AFB1-2,3-epoxide and prevents its interaction with DNA. Since only a small percentage of ingested AFB1 (< 13%) forms liver DNA adducts, inhibitor-mediated alterations in even a minor amount of detoxication by this pathway could be significant. This reaction has further been implicated as significant in anticarcinogenesis and species differences to AFB1 (51, 52) . To investigate more directly the possible role of this pathway in trout AFB1 carcinogenesis and its modulation, authentic AFB1-GSH conjugate was synthesized and used as an HPLC marker (53) . Table 3 depicts the most significant results of these studies. Formation of AFB1 was found not to exceed 1% of total AFB1-derived metabolites in bile of trout fed control TREATMENT cytes would also be seen in vivo, and whether inhibitors might alter overall adduct persistence or repair. Liver nuclei were isolated from fish fed control, PCB, or I3C diets, and the DNA purified for determination of total level of adducts at various times after exposure. The results are depicted in Figure 3 . As previously observed, peak adduct formation occurred in control trout 24 to 48 hr after AFB1 exposure. Dietary pretreatment with each ofthe inhibitors significantly reduced the level of peak adduct formation compared to control. [Only the 24-hr data point has been studied for BNF, with a reduction of adducts to 44% of control (8)]
. Surprisingly, I3C, the inhibitor with the weakest effects on enzyme *1 PCB FIGURE 2. Bile aflatoxin metabolites from the gall bladder 24 hr after IP injection of AFB1 into trout prefed PCB, BNF, or I3C. Samples were taken directly from fish treated in Fig. 1 and analyzed for AFB1-derived metabolites as described (50). , and sampled 1/2, 1, 2, 7, and 21 days later, without feeding. Liver nuclear DNA was purified and ABF1-DNA binding determined as described (48) . Data were weight-corrected to equal dosage. Each value represents the mean (± SEM) of three groups of three pooled individuals. These graphs are taken from previous publications (48) and (49) Specific studies on the mechanisms of anti-initiation by BNF, 13C, and PCB for AFB1 carcinogenesis in trout have shown that dietary pretreatment by each of these three modulators leads to reduced initial formation of AFB1-DNA adducts in vivo and in vitro. The precise mechanisms by which this is achieved differ. BNF and PCB inhibit at least in part through induction of cytochrome P448, and associated enhancement of AFM1 and AFL-Mi-glucuronide detoxication reactions.
PCB also appears to enhance overall rates of AFB1 metabolism in intact trout and in isolated hepatocytes. I3C shows the weakest effects on these pathways but, at the doses studied, had the strongest effects on reducing DNA adduct formation. Addition of 13C itself does not alter AFB1 metabolism or DNA binding in control hepatocytes (49) . Hence the mechanisms) through which I3C-mediated AFB1 binding reduction occurs are not clearly understood, but may involve direct or indirect effects of I3C metabolites on AFB1 metabolism or transport.
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